Search Results

There are 6238 results for: content related to: Anticoagulation in cirrhosis: Ready … set … wait!

  1. Investigation of freezing- and thawing-induced biological, chemical, and physical changes to enoxaparin solution

    Journal of Pharmaceutical Sciences

    Volume 98, Issue 3, March 2009, Pages: 1118–1128, Rahul P. Patel, Christian Narkowicz and Glenn A. Jacobson

    Version of Record online : 25 JUL 2008, DOI: 10.1002/jps.21483

  2. Monitoring of Enoxaparin Level Using Citrated Clotting Time during Percutaneous Coronary Intervention

    Journal of Interventional Cardiology

    Volume 17, Issue 5, October 2004, Pages: 307–313, JOSE G. DÍEZ, BENJAMIN Y.C. CHEONG, LAWRENCE P. O'MEALLIE and ECKHARD U. ALT

    Version of Record online : 18 OCT 2004, DOI: 10.1111/j.1540-8183.2004.04030.x

  3. You have free access to this content
    Economic Evaluation of Enoxaparin as Postdischarge Prophylaxis for Deep Vein Thrombosis (DVT) in Elective Hip Surgery

    Value in Health

    Volume 3, Issue 6, November/December 2000, Pages: 397–406, Linda Mary Davies, Gerald Anthony Richardson and Alexander T Cohen

    Version of Record online : 7 JUL 2008, DOI: 10.1046/j.1524-4733.2000.36005.x

  4. Investigation of the effect of heating on the chemistry and antifactor Xa activity of enoxaparin

    Journal of Pharmaceutical Sciences

    Volume 98, Issue 5, May 2009, Pages: 1700–1711, Rahul P. Patel, Christian Narkowicz and Glenn A. Jacobson

    Version of Record online : 31 OCT 2008, DOI: 10.1002/jps.21556

  5. Low-molecular-weight heparin during percutaneous coronary interventions: Rationale, results, and recommendations

    Catheterization and Cardiovascular Interventions

    Volume 60, Issue 2, October 2003, Pages: 185–193, Glenn N. Levine and James J. Ferguson III

    Version of Record online : 23 SEP 2003, DOI: 10.1002/ccd.10640

  6. The Role of Enoxaparin in Interventional Management of Patients with Acute Coronary Syndromes

    Journal of Interventional Cardiology

    Volume 16, Issue 5, October 2003, Pages: 357–366, CINDY L. GRINES and WILLIAM O'NEILL

    Version of Record online : 20 OCT 2003, DOI: 10.1046/j.1540-8183.2003.01000.x

  7. A novel enoxaparin regime for ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A WEST sub-study

    Catheterization and Cardiovascular Interventions

    Volume 70, Issue 3, 1 September 2007, Pages: 341–348, Robert C. Welsh, Phillip Gordon, Cynthia M. Westerhout, Christopher E. Buller, Blair O'Neill and Paul W. Armstrong

    Version of Record online : 12 FEB 2007, DOI: 10.1002/ccd.21062

  8. Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin

    Journal of Pharmaceutical Sciences

    Volume 96, Issue 8, August 2007, Pages: 2090–2106, Shuhua Bai, Chandan Thomas and Fakhrul Ahsan

    Version of Record online : 7 FEB 2007, DOI: 10.1002/jps.20849

  9. You have free access to this content
    Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)

    Intervention Review

    The Cochrane Library

    Raza Alikhan, Rachel Forster and Alexander T Cohen

    Published Online : 7 MAY 2014, DOI: 10.1002/14651858.CD003747.pub4

  10. The design of venous thromboembolism prophylaxis trials: Fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery

    International Journal of Clinical Practice

    Volume 58, Issue 5, May 2004, Pages: 483–493, A.G.G. Turpie

    Version of Record online : 28 MAY 2004, DOI: 10.1111/j.1368-5031.2004.00183.x

  11. Retrospective evaluation of antithrombin III supplementation in neonates and infants receiving enoxaparin for treatment of thrombosis

    Pediatric Blood & Cancer

    Volume 61, Issue 6, June 2014, Pages: 1063–1067, Amy Corder, Kristin Held and Alexandra Oschman

    Version of Record online : 20 DEC 2013, DOI: 10.1002/pbc.24899

  12. You have full text access to this OnlineOpen article
    Quantitative Systems Pharmacology Model to Predict the Effects of Commonly Used Anticoagulants on the Human Coagulation Network

    CPT: Pharmacometrics & Systems Pharmacology

    S Hartmann, K Biliouris, LJ Lesko, U Nowak-Göttl and MN Trame

    Version of Record online : 20 SEP 2016, DOI: 10.1002/psp4.12111

  13. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair

    Intervention Review

    The Cochrane Library

    Rachel Forster and Marlene Stewart

    Published Online : 30 MAR 2016, DOI: 10.1002/14651858.CD004179.pub2

  14. Changes in Enoxaparin Pharmacokinetics During Pregnancy and Implications for Antithrombotic Therapeutic Strategy

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 3, September 2008, Pages: 370–377, C Lebaudy, JS Hulot, Z Amoura, N Costedoat-Chalumeau, R Serreau, A Ankri, J Conard, A Cornet, M Dommergues, JC Piette and P Lechat

    Version of Record online : 23 APR 2008, DOI: 10.1038/clpt.2008.73

  15. You have free access to this content
    Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)-5 trial

    Journal of Thrombosis and Haemostasis

    Volume 8, Issue 2, February 2010, Pages: 243–249, J. A. M. ANDERSON, J. HIRSH, S. YUSUF, M. JOHNSTON, R. AFZAL, S. R. MEHTA, K. A. A. FOX, A. BUDAJ and J. W. EIKELBOOM

    Version of Record online : 26 NOV 2009, DOI: 10.1111/j.1538-7836.2009.03705.x

  16. Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study

    Acta Neurologica Scandinavica

    Volume 106, Issue 2, August 2002, Pages: 84–92, M. Hillbom, T. Erilä, K. Sotaniemi, T. Tatlisumak, S. Sarna and M. Kaste

    Version of Record online : 27 JUN 2002, DOI: 10.1034/j.1600-0404.2002.01215.x

  17. You have free access to this content
    Women’s views on and adherence to low-molecular-weight heparin therapy during pregnancy and the puerperium

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 12, December 2012, Pages: 2526–2534, J. P. PATEL, V. AUYEUNG, R. K. PATEL, M. S. MARSH, B. GREEN, R. ARYA and J. G. DAVIES

    Version of Record online : 12 DEC 2012, DOI: 10.1111/jth.12020

  18. You have free access to this content
    Inhibitors of propagation of coagulation: factors V and X

    British Journal of Clinical Pharmacology

    Volume 72, Issue 4, October 2011, Pages: 563–580, Vincenzo Toschi and Maddalena Lettino

    Version of Record online : 9 SEP 2011, DOI: 10.1111/j.1365-2125.2011.04001.x

  19. Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: A subgroup analysis from the SYNERGY trial

    Catheterization and Cardiovascular Interventions

    Volume 75, Issue 6, 1 May 2010, Pages: 928–935, Marc Cohen, Glenn N. Levine, Karen S. Pieper, Lan Lan, Elliott M. Antman, Philip E. Aylward, Harvey D. White, Neal S. Kleiman, Robert M. Califf and Kenneth W. Mahaffey

    Version of Record online : 27 OCT 2009, DOI: 10.1002/ccd.22340

  20. You have free access to this content
    Anti-PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non-drug risk factors and evidence for a stoichiometry-based model of immunization

    Journal of Thrombosis and Haemostasis

    Volume 8, Issue 3, March 2010, Pages: 504–512, T. E. WARKENTIN, R. J. COOK, V. J. MARDER and A. GREINACHER

    Version of Record online : 24 DEC 2009, DOI: 10.1111/j.1538-7836.2009.03735.x